Story perspectives

Revolutionary Laser Trials for AMD Set to Begin 2026

11/2/2025

31 6

Summary

Story summary

Advancements in retinal disease treatments emphasize personalized strategies using multiple options and artificial intelligence.
Current therapies, including anti-VEGF and laser treatments, do not fully address the complexities of wet age-related macular degeneration (AMD).
In Finland, clinical trials will test a new laser treatment for dry AMD beginning spring 2026.
If successful, the method could reach hospitals within about three years and help millions globally.

1 of 1

Story summary

Advancements in retinal disease treatments emphasize personalized strategies using multiple options and artificial intelligence.
Current therapies, including anti-VEGF and laser treatments, do not fully address the complexities of wet age-related macular degeneration (AMD).
In Finland, clinical trials will test a new laser treatment for dry AMD beginning spring 2026.
If successful, the method could reach hospitals within about three years and help millions globally.